SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-21-024951
Filing Date
2021-06-21
Accepted
2021-06-21 16:05:52
Documents
2
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4755
2 EX-24 DOCUMENT attachment1.htm EX-24 4534
  Complete submission text file 0000899243-21-024951.txt   10697
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Smith-Whitley Kim (Reporting) CIK: 0001860297 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37539 | Film No.: 211030511